Zimmer Biomet Holdings Inc

Price has formed a Bearish Pivot Point beneath converged 9-, 20-, and 50-day EMAs, signaling structural downside repair. The recent bounce off the 200-day SMA remains relief only, with no reclaim of key moving averages. Medium-term bias is bearish, and short-term conditions favor selling into rallies toward the 95.3–96.0 resistance band. Long-term uptrend persists above the 200-day SMA, but only sustained acceptance above the short-term EMAs and 50-day SMA would reverse this stance.

• ↑High earnings yield indicates potential value opportunity.
• ↑Q2 2026 revenue est. $2.14B, up 2.9% YoY.
• ↓Negative profitability factors signal margin inefficiencies.